Insights into Vestibular Migraine: Diagnostic Challenges, Differential Spectrum and Therapeutic Horizons
Journal of Clinical Medicine · 08.07.2025 · 14 (14) · 4828
DOI: 10.3390/jcm14144828 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.07.2025. Verfasst von Marlon Cantillo-Martínez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hospital Occidente de Kennedy, Bogota 111611, Colombia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vestibular migraine (VM) commonly causes recurrent vertigo, but diagnosing and managing it can be difficult due to symptom overlap with other vestibular and headache disorders. This review provides a comprehensive update on VM, beginning with the diagnostic criteria established by the International Headache Society and the Bárány Society, who have increased awareness of this condition. While the pathophysiology is not yet completely understood, there is evidence of a complex interaction between the nociceptive and vestibular systems. Treatment approaches are primarily empirical and lack robust, high-quality evidence. Often, antihistamines and benzodiazepines are used for quick symptom relief, while the efficacy of triptans is still uncertain. Preventive measures include lifestyle changes, vestibular rehabilitation, oral migraine prophylactics, Botulinum toxin type A, and, more recently, CGRP-targeted therapies. Due to diagnostic uncertainties and the absence of standardised treatment protocols, further research—particularly randomised controlled trials—is crucial for establishing evidence-based guidelines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Hospital Occidente de Kennedy, Bogota 111611, Colombia.
- Department of Otorhinolaryngology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
- Department of Neurology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
- School of Medicine, University of Navarra, 31009 Pamplona, Spain.
- Headache Group, NIHR King's Clinical Research Facility & SLaM Biomedical Research Centre, King's College London, London SE5 9RS, UK.
- Wolfson SPaRC, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 9PJ, UK.
ORCID-Profile: Marlon Cantillo-Martínez, Nicolás Pérez-Fernández, Pablo Irimia
Zitieren
APA
Cantillo-Martínez, M., Lorente-Piera, J., Manrique-Huarte, R., Sánchez-Del-Río, M., Pérez-Fernández, N., Chico-Vila, C., Moreno-Ajona, D., & Irimia, P. (2025). Insights into Vestibular Migraine: Diagnostic Challenges, Differential Spectrum and Therapeutic Horizons. Journal of Clinical Medicine, 14(14), 4828. https://doi.org/10.3390/jcm14144828
Vancouver
Cantillo-Martínez M, Lorente-Piera J, Manrique-Huarte R, Sánchez-Del-Río M, Pérez-Fernández N, Chico-Vila C, et al. Insights into Vestibular Migraine: Diagnostic Challenges, Differential Spectrum and Therapeutic Horizons. Journal of Clinical Medicine. 2025;14(14):4828. doi:10.3390/jcm14144828
BibTeX
@article{CantilloMartnez2025,
author = {Cantillo-Martínez, Marlon and Lorente-Piera, Joan and Manrique-Huarte, Raquel and Sánchez-Del-Río, Margarita and Pérez-Fernández, Nicolás and Chico-Vila, Carlos and Moreno-Ajona, David and Irimia, Pablo},
title = {Insights into Vestibular Migraine: Diagnostic Challenges, Differential Spectrum and Therapeutic Horizons},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {14},
pages = {4828},
doi = {10.3390/jcm14144828}
}
EUVIMED